Literature DB >> 10970052

Tau pathology: a marker of neurodegenerative disorders.

A Delacourte1, L Buée.   

Abstract

Tau is not only a basic component of neurofibrillary degeneration, but is also an aetiological factor, as demonstrated by mutations on the tau gene responsible for frontotemporal dementias with parkinsonism linked to chromosome 17. Polymorphisms on the tau gene and the hierarchical invasion of neocortical areas by tau pathology in numerous sporadic neurodegenerative diseases also suggest that tau pathology is a primary pathogenic event in non-familial dementing diseases and a lead for solid diagnostic and therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970052     DOI: 10.1097/00019052-200008000-00002

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  27 in total

Review 1.  Progressive supranuclear palsy.

Authors:  K Tawana; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

2.  Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.

Authors:  Anna Kremer; Hervé Maurin; David Demedts; Herman Devijver; Peter Borghgraef; Fred Van Leuven
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

Review 3.  Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.

Authors:  Dick Terwel; Ilse Dewachter; Fred Van Leuven
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

4.  Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity.

Authors:  Jacek Biernat; Yong-Zhong Wu; Thomas Timm; Qingyi Zheng-Fischhöfer; Eckhard Mandelkow; Laurent Meijer; Eva-Maria Mandelkow
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

5.  Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study.

Authors:  A Modoni; G Silvestri; M Gabriella Vita; D Quaranta; P A Tonali; C Marra
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

6.  Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution.

Authors:  Yanfang Rui; Jiaping Gu; Kuai Yu; H Criss Hartzell; James Q Zheng
Journal:  Mol Brain       Date:  2010-03-26       Impact factor: 4.041

7.  Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease.

Authors:  Tomasz Jaworski; Sebastian Kügler; Fred Van Leuven
Journal:  Int J Alzheimers Dis       Date:  2010-08-24

8.  Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.

Authors:  Elyse Rosa; Sujeivan Mahendram; Yazi D Ke; Lars M Ittner; Stephen D Ginsberg; Margaret Fahnestock
Journal:  Neurobiol Aging       Date:  2016-08-31       Impact factor: 4.673

Review 9.  Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.

Authors:  A Rostagno; J L Holton; T Lashley; T Revesz; Jorge Ghiso
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

10.  Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsy.

Authors:  A Martínez; E Dalfó; G Muntané; I Ferrer
Journal:  J Neural Transm (Vienna)       Date:  2007-08-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.